Both in Pharmaceuticals
Revelation Biosciences vs Ernexa Therapeutics
Over the past year REVB returned −86.8% and ERNA returned −95.2%; their daily moves had a correlation of -0.01.
REVB −86.8% ERNA −95.2%Growth of $1, one year, split-adjusted
| Metric | REVB | ERNA |
|---|---|---|
| Price | $4.43 | $2.02 |
| Market cap | $2.5M | $2.4M |
| Today | +9.38% | +3.59% |
| 1 month | −18.6% | −25.2% |
| 6 months | −40.9% | −49.4% |
| Year to date | −80.2% | −93.3% |
| 1 year | −87.3% | −95.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.5M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 551.9% | 78.3% |
| Short % of float | 0.2% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).